Lundbeck Inc. And Otsuka Pharmaceutical Co., Ltd. To Co-Develop A Vaccine, Lu AF20513, Their Third Collaborative Development Project To Tackle Alzheimer’s Disease
Published: Dec 11, 2013
Valby, Denmark and Tokyo, Japan, 11 December 2013 - H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that they will further expand their collaboration to include the development of Lu AF20513, an investigational vaccine candidate against Alzheimer’s disease.
Help employers find you! Check out all the jobs and post your resume.